SEEL
Seelos Therapeutics Inc
$0.3
Earnings Summary
Revenue | $0.65Mn |
Net Profits | $-5.45Mn |
Net Profit Margins | -835.07% |
Highlights
Seelos Therapeutics Inc’s revenue jumped +Inf% since last year same period to $0.65Mn in the Q4 2023. On a quarterly growth basis, Seelos Therapeutics Inc has generated 60.84% jump in its revenue since last 3-months.
Seelos Therapeutics Inc’s net profit jumped 71.39% since last year same period to $-5.45Mn in the Q4 2023. On a quarterly growth basis, Seelos Therapeutics Inc has generated -151.94% fall in its net profits since last 3-months.
Seelos Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -835.07% in the Q4 2023. On a quarterly growth basis, Seelos Therapeutics Inc has generated -132.3% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Seelos Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.48 |
EPS Estimate Current Year | -1.48 |
Highlights
Seelos Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.48 - a -85% fall from last quarter’s estimates.
Seelos Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.48.
Key Ratios
Key ratios of the Seelos Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.79 |
Highlights
Seelos Therapeutics Inc’s earning per share (EPS) fell -364.71% since last year same period to -0.79 in the Q4 2023. This indicates that the Seelos Therapeutics Inc has generated -364.71% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-14 | -0.06 | -0.12 | -100% |
2023-12-31 | -0.8 | -0.79 | 1.25% |
2023-08-11 | -0.09 | -0.22 | -144.44% |
2023-05-12 | -0.11 | -0.12 | -9.09% |
₹0 US Stocks a/c Opening Fee